Demonstrating Biosimilarity: Guidance from the FDA
June 5, 2014
Axinn Counsel Stacie Ropka presented, "Demonstrating Biosimilarity: Guidance from the FDA," at the American Conference Institute's fifth annual Summit on Biosimilars.
Axinn Counsel Stacie Ropka presented, "Demonstrating Biosimilarity: Guidance from the FDA," at the American Conference Institute's fifth annual Summit on Biosimilars.